Literature DB >> 9199028

[Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group].

H K Poulsen1, M Jacobsen, K Bertelsen, J E Andersen, S Ahrons, J E Bock, E Bostofte, S A Engelholm, B Hølund, A K Jakobsen, H Kiaer, M H Nyland, P H Pedersen, I S Christophersen.   

Abstract

In an attempt to create uniform nationwide guidelines for the management of all stages of endometrial carcinoma, and to limit the use of adjuvant radiation therapy in stage I disease to high-risk patients only, a protocol was developed by the Danish Endometrial Cancer group (DEMCA). From September 1986 through August 1988, 1214 women in Denmark with newly diagnosed carcinoma of the endometrium have been treated according to this protocol. This figure represents all endometrial carcinomas diagnosed in Denmark during this two-year period. The primary treatment was total abdominal hysterectomy and bilateral salpingo-oophorectomy, no preoperative radiation therapy was delivered. In 1039 cases no macroscopic residual tumour and/or microscopic tumor tissue in the resection margins was found following surgery. Based on surgery and histopathology, these patients were classified as: P-stage I low risk (n = 641), P-stage I high risk (n = 235), P-stage II (n = 105) and P-stage III, Group 1 (n = 58). No postoperative radiation therapy was given to P-I low risk cases. P-I high risk, P-II, and P-III (Group 1) cases received external radiation therapy. Recurrence rate at 68-92 months follow-up was 45/641 (7%) in P-I low risk, 36/235 (15%) in P-I high risk, 30/105 (29%) in P-II, and 27/58 (47%) in P-III (Group 1) cases. Fifteen of 17 vaginal recurrences in P-I low risk cases were salvaged (mean observation time 61 months). In this population-based investigation it has been shown that P-stage low-risk patients are adequately treated by total abdominal hysterectomy and bilateral salpingo-oophorectomy, and that no pre- or postoperative radiation therapy is necessary.

Entities:  

Mesh:

Year:  1997        PMID: 9199028

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  5 in total

Review 1.  Endometrial Cancer: Transitioning from Histology to Genomics.

Authors:  Cristina Mitric; Marcus Q Bernardini
Journal:  Curr Oncol       Date:  2022-01-31       Impact factor: 3.677

Review 2.  Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments?

Authors:  Heike R Scheithauer; Diana S Schulz; Claus Belka
Journal:  Radiat Oncol       Date:  2011-11-25       Impact factor: 3.481

3.  Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.

Authors:  Robert Foerster; Robert Kluck; Nathalie Arians; Stefan Rieken; Harald Rief; Sebastian Adeberg; Tilman Bostel; Ingmar Schlampp; Juergen Debus; Katja Lindel
Journal:  Radiat Oncol       Date:  2015-07-16       Impact factor: 3.481

4.  Adjuvant brachytherapy for Stage IB Grade 2 endometrial carcinoma: Multivariate analysis of a single institution experience.

Authors:  Margarita Tokar; Michael Meirovich; Dmitri Bobilev; Wilmosh Mermershtain
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Apr-Jun

5.  Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer.

Authors:  Sylwia Kellas-Ślęczka; Piotr Wojcieszek; Brygida Białas
Journal:  J Contemp Brachytherapy       Date:  2012-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.